Therapy But Better – Lifestyle
Author:
BioInvent International
BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio
April 29, 2026
BioInvent International AB: Interim Report January – March 2026
April 29, 2026
BioInvent to Present Data of BI-1808 Plus KEYTRUDA(R) (Pembrolizumab) in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting
April 21, 2026
BioInvent International AB Publishes Annual Report 2025
March 31, 2026
BioInvent Achieves Phase 3 Milestone for HMI-115 in Endometriosis
March 26, 2026